| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.0009 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |